Your browser doesn't support javascript.
loading
Efficacy of a novel low-cost torchlight transcorneal transillumination for diode laser transscleral cyclophotocoagulation in adult glaucoma.
Thattaruthody, Faisal; Chauhan, Neha; Choudhary, Sandeep; Raj, Srishti; Pandav, Surinder Singh; Kaushik, Sushmita.
Affiliation
  • Thattaruthody F; Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Chauhan N; Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Choudhary S; Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Raj S; Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Pandav SS; Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Kaushik S; Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Eur J Ophthalmol ; : 11206721241253305, 2024 May 06.
Article in En | MEDLINE | ID: mdl-38710194
ABSTRACT

PURPOSE:

To study the outcomes of diode laser transscleral cyclophotocoagulation (TSCPC) with trans-corneal transillumination using a novel low-cost torchlight method in refractory glaucoma. METHODS AND

ANALYSIS:

This prospective interventional study included patients with refractory glaucoma who underwent TSCPC with trans-corneal transillumination (TSCPC-TI) using a novel low-cost torchlight method. Patients completing a minimum 6-month follow-up were analyzed. They were compared to a historical control group of patients who underwent TSCPC without transillumination (TSCPC-No TI) at 6-month follow-up period. We analyzed the mean laser energy delivered, post-laser intraocular pressure (IOP) reduction, number of antiglaucoma medications (AGM), the requirement of retreatment and complications of the procedure in both groups.

RESULTS:

32 eyes of 29 patients comprised the TSCPC-TI group and were compared with 39 eyes of 37 patients in the TSCPC-No TI group. The TSCPC-TI group required lower energy than the TSCPC-No TI group (46.15 ± 22.8 Vs 80.65 ± 56.1 J p < 0.001). At 6-month follow-up, the TSCPC-TI group required lesser AGM for IOP control (2.33 ± 1.02 vs 3.02 ± 1.32 p = 0.01). There was a significantly reduced dependence of oral acetazolamide in the TSCPC-TI group at 6 months follow-up (15.6% vs 41% p = 0.03%). The success and response rates were 71.8% Vs 23.1%; p < 0.0001 and 87.5% Vs 51.2%; p = 0.001 significantly high in the TSCPC-TI group. The TSCPC-No TI group had a significantly high failure rate (12.5% Vs 48.2% p = 0.001). Hypotony (n = 1) and phthisis (n = 2) were noted TSCPC-No TI group.

CONCLUSIONS:

TSCPC with transillumination with a low-cost torchlight resulted in a more efficient and effective cycloablation than TSCPC without transillumination.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Ophthalmol Journal subject: OFTALMOLOGIA Year: 2024 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Ophthalmol Journal subject: OFTALMOLOGIA Year: 2024 Document type: Article Affiliation country: India